Home » Stocks » CLCS

Cell Source, Inc. (CLCS)

Stock Price: $1.55 USD 0.00 (0.00%)
Updated Feb 24, 2021 9:30 AM EST - Market closed
Market Cap 57.53M
Revenue (ttm) n/a
Net Income (ttm) -4.72M
Shares Out 31.85M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 24
Last Price $1.55
Previous Close $1.55
Change ($) 0.00
Change (%) 0.00%
Day's Open 1.55
Day's Range 1.55 - 1.55
Day's Volume 0
52-Week Range 0.4101 - 2.55

News

There are no news available yet.

About CLCS

Cell Source, a cell therapy company, focuses on developing and commercializing immunotherapy medicines in Israel. The company's lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is used in various applications, such as treatment of lymphoma, leukemia, and multiple myeloma; and facilitating the stem cell transplantation acceptance, as well as treatment of end stage kidney disease and other non-malignant or... [Read more...]

Industry
Biotechnology
Founded
2011
Stock Exchange
OTCMKTS
Ticker Symbol
CLCS
Full Company Profile

Financial Performance

Financial Statements